426 related articles for article (PubMed ID: 3275559)
21. Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus.
Schernthaner G; Banatvala JE; Scherbaum W; Bryant J; Borkenstein M; Schober E; Mayr WR
Lancet; 1985 Sep; 2(8456):630-2. PubMed ID: 2863632
[TBL] [Abstract][Full Text] [Related]
22. HLA-associated heterogeneity of the humoral response to islet antigens in insulin-dependent diabetes.
Delamaire M; Timsit J; Caillat-Zucman S; Maugendre D; Roussely H; Semana G; Yamamoto AM; van Endert P; Boitard C; Genetet B
J Autoimmun; 1995 Oct; 8(5):645-57. PubMed ID: 8579721
[TBL] [Abstract][Full Text] [Related]
23. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
[TBL] [Abstract][Full Text] [Related]
24. [The role of genetic and immunological factors in the etiology of insulin-dependent diabetes].
Deschamps I; Hors J; Robert JJ
Schweiz Med Wochenschr; 1990 Jan; 120(3):46-53. PubMed ID: 2405478
[TBL] [Abstract][Full Text] [Related]
25. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
26. Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population.
Pagano G; Cavallo-Perin P; Cavalot F; Dall'Omo AM; Masciola P; Suriani R; Amoroso A; Curtoni SE; Borelli I; Lenti G
Diabetes; 1987 Jul; 36(7):859-63. PubMed ID: 3556283
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
28. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
[TBL] [Abstract][Full Text] [Related]
29. MHC classes I, II, III antigens study in 70 insulin-dependent diabetics with associated auto-immune diseases.
Gony J; Vexiau P; Lhomme C; Marcelli A; Poirier JC; Bochu V; Cathelineau G; Assan R; Deschamps I; Hors J
Tissue Antigens; 1988 May; 31(5):229-34. PubMed ID: 3400088
[TBL] [Abstract][Full Text] [Related]
30. A search for heterogeneity in insulin dependent diabetes mellitus (IDDM): HLA and autoimmune studies in simplex, multiplex and multigenerational families.
Anderson CE; Hodge SE; Rubin R; Rotter JI; Terasaki PI; Irvine WJ; Rimoin DL
Metabolism; 1983 May; 32(5):471-7. PubMed ID: 6341762
[TBL] [Abstract][Full Text] [Related]
31. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
[TBL] [Abstract][Full Text] [Related]
32. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
33. Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese HLA antigens and organ-specific autoantibodies.
Kida K; Mimura G; Kobayashi T; Nakamura K; Sonoda S; Inouye H; Tsuji K
Diabetologia; 1989 Jan; 32(1):34-9. PubMed ID: 2651187
[TBL] [Abstract][Full Text] [Related]
34. A comparison of childhood and adult type I diabetes mellitus.
Karjalainen J; Salmela P; Ilonen J; Surcel HM; Knip M
N Engl J Med; 1989 Apr; 320(14):881-6. PubMed ID: 2648146
[TBL] [Abstract][Full Text] [Related]
35. Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes.
Nepom BS; Schwarz D; Palmer JP; Nepom GT
Diabetes; 1987 Jan; 36(1):114-7. PubMed ID: 3491769
[TBL] [Abstract][Full Text] [Related]
36. HLA and autoimmune endocrine disease 1985.
Farid NR; Thompson C
Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
[TBL] [Abstract][Full Text] [Related]
37. Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4.
Eisenbarth GS; Srikanta S; Fleischnick E; Ganda OP; Jackson RA; Brink SJ; Soeldner JS; Yunis EJ; Alper C
Diabetes Care; 1985; 8(5):477-80. PubMed ID: 3876922
[TBL] [Abstract][Full Text] [Related]
38. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
[TBL] [Abstract][Full Text] [Related]
39. Organ-specific autoantibodies in HLA genotyped insulin-dependent diabetes mellitus families.
Vexiau P; Helmy-Khalil S; Deschamps I; Homberg JC; Cathelineau G; Woimant G; Marcelli-Barge A; Poirier JC; Hors J
J Autoimmun; 1988 Jun; 1(3):253-61. PubMed ID: 3075129
[TBL] [Abstract][Full Text] [Related]
40. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
